Marex Group’s Hims & Hers Health HIMS Stock Holding History

Marex Group’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.8M	Sell	973,771 -365,043	-27%	-$9.8M	0.14%	113
2026 Q1	$27.8M	Sell	1,338,814 -1,080,704	-45%	-$25.5M	0.18%	109
2025 Q4	$78.6M	Buy	2,419,518 +1,496,707	+162%	+$64.1M	0.49%	51
2025 Q3	$52.3M	Sell	922,811 -158,665	-15%	-$8.13M	0.37%	63
2025 Q2	$53.6M	Buy	1,081,476 +756,723	+233%	+$34.2M	0.47%	49
2025 Q1	$9.6M	Buy	324,753 +312,465	+2,543%	+$11.6M	0.18%	71
2024 Q4	$297K	Sell	12,288 -93,619	-88%	-$2.32M	0.01%	454
2024 Q3	$1.95M	Buy	105,907 +907	+0.9%	+$16.2K	0.04%	153
2024 Q2	$2.12M	Buy	+105,000	New	+$1.75M	0.06%	155

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marex Group's HIMS Position: Q2 2026 in Review

Marex Group reduced its Hims & Hers Health (HIMS) stake by 27% in Q2 2026, selling an estimated $9.8M and leaving 973,771 shares worth $33.8M. The position accounts for 0.14% of the portfolio, ranked #113.

Marex Group first reported a position in HIMS in Q2 2024 and has held it in 9 quarters since. The position peaked at $78.6M in Q4 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Marex Group held 973,771 shares of Hims & Hers Health worth $33.8M as of Q2 2026.
Marex Group sold 365,043 Hims & Hers Health shares in Q2 2026, an estimated $9.8M.
Hims & Hers Health made up 0.14% of Marex Group's portfolio in Q2 2026, its #113 holding.
Marex Group first reported a position in Hims & Hers Health in Q2 2024 and has held it in 9 quarters since.
Marex Group's Hims & Hers Health position peaked at $78.6M in Q4 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.